Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03616171 · ClinicalTrials.gov registry record · NA
A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03616171 is a NA study that has completed, run by Emory University. The registered enrollment target is 6 participants.
The verdict
NCT03616171, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study is a prospective unblinded randomized trial to evaluate the feasibility of conducting a sleep extension intervention trial and the sleep extension intervention among the young adults. The study also wants to assess whether a sleep-extension intervention has an impact on the insulin resistance levels of young adults. The intervention consists of an education session and to extend the sleep time at least one hour but can be up to 2 hours per night for 4 weeks.
Interventions
- OTHER Control
- BEHAVIORAL SLEEP-Extend intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-08-30 |
| Est. Completion | 2018-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03616171
The ClinicalTrials.gov registry entry for NCT03616171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03616171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03616171 about?
NCT03616171 is a clinical study titled "A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes". The study is a prospective unblinded randomized trial to evaluate the feasibility of conducting a sleep extension intervention trial and the sleep extension intervention among the young adults. The study also wants to assess whether a sleep-extension intervention has an impact on the insulin resista...
What is the current status of trial NCT03616171?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-08-30. Estimated completion is 2018-04-02.
What interventions are being tested in trial NCT03616171?
The interventions under investigation include: Control (OTHER), SLEEP-Extend intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03616171?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.